# OnCo record eisbach-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/eisbach-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "eisbach-bio" ;
  schema:name "Eisbach Bio"@en ;
  schema:description "Eisbach Bio develops small-molecule cancer medicines. Its lead tablet, EIS-12656, blocks a DNA repair enzyme called ALC1 and is in an early trial in advanced solid tumours with defects in DNA repair."@en ;
  schema:url <https://onco.cc/companies/eisbach-bio/>, <https://www.eisbach.bio/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.eisbach.bio/>, <https://www.eisbach.bio/post/eisbach-announces-first-patient-dosed-in-phase-1-2-trial-for-eis-12656-a-first-in-class-allosteric> ;
  schema:addressCountry "DE" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/ai-drug-design/> ;
  onco:trials <https://onco.cc/trials/nct06525298/> .